SCHEMBL20155044

SCHEMBL20155044

COCCn1cc2c(O)nccc2n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPO P05164 2/20 0.38
MAP4K4 O95819 1/20 0.37
EGFR P00533 1/20 0.37
FRK P42685 1/20 0.37
MAPK9 P45984 1/20 0.37
CSNK1D P48730 1/20 0.37
SLK Q9H2G2 1/20 0.37
ATM Q13315 1/20 0.35
PDE4D Q08499 2/20 0.34
PTPN11 Q06124 1/20 0.34
IRAK4 Q9NWZ3 3/20 0.33
IKBKE Q14164 3/20 0.33
TBK1 Q9UHD2 3/20 0.33
BRAF P15056 1/20 0.33
MAPK3 P27361 1/20 0.33
MAPK1 P28482 1/20 0.33
LRRK2 Q5S007 1/20 0.33
DYRK1A Q13627 2/20 0.32
NFATC1 O95644 1/20 0.32
GSK3B P49841 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20155042 0.82 MAP4K4 (0.42) MPOMAP4K4EGFRFRKMAPK9
SCHEMBL20155687 0.80 ATM (0.36) ATMPDE4D
SCHEMBL20155043 0.72 LRRK2 (0.34) MAP4K4EGFRFRKMAPK9CSNK1D
SCHEMBL3348756 0.72 MPO (0.46) MPOMAP4K4EGFRFRKMAPK9
SCHEMBL21631825 0.70 PTPN11 (0.41) MPOMAP4K4EGFRFRKMAPK9
SCHEMBL14994209 0.69 PARP1 (0.37) MPOPTPN11IRAK4MEN1KMT2A
SCHEMBL2596825 0.68 MAP4K4 (0.37) MPOMAP4K4EGFRFRKMAPK9
SCHEMBL20155000 0.67 ADORA2A (0.34) MPODYRK1A
SCHEMBL28237663 0.67 MPO (0.46) MPOIRAK4KMT2A
SCHEMBL14909620 0.67 ALDH1A1 (0.43) MPOIRAK4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018086604-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATIONS THEREOF 山东罗欣药业集团股份有限公司 2018-05-17 WO disclosed